Those who invested in Blueprint Medicines (NASDAQ:BPMC) five years ago are up 41%
yahoo.com
news
2022-05-30 15:37:13

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to see it rise more than the market average. But Blueprint Medicines Corporation (NASDAQ:BPMC) has fallen short of that second goal, with a share price rise of 41% over five years, which is below the market return. Unfortunately the share price is down 38% in the last year.

So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.
